Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model

The newly emerged novel coronavirus, SARS-CoV-2, the causative agent of COVID-19 has proven to be a threat to the human race globally, thus, vaccine development against SARS-CoV-2 is an unmet need driving mass vaccination efforts. The receptor binding domain of the spike protein of this coronavirus ...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrivastava, Tripti, Singh, Balwant, Rizvi, Zaigham Abbas, Verma, Rohit, Goswami, Sandeep, Vishwakarma, Preeti, Jakhar, Kamini, Sonar, Sudipta, Mani, Shailendra, Bhattacharyya, Sankar, Awasthi, Amit, Surjit, Milan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182375/
https://www.ncbi.nlm.nih.gov/pubmed/34108961
http://dx.doi.org/10.3389/fimmu.2021.641447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182375/
https://www.ncbi.nlm.nih.gov/pubmed/34108961
http://dx.doi.org/10.3389/fimmu.2021.641447

Ejemplares similares